AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
24 hedge funds and large institutions have $26.7M invested in Agile Therapeutics in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
24
Holding in Top 10
1
Calls
$217K
Puts
–
Top Buyers
| 1 | +$1.43M | |
| 2 | +$175K | |
| 3 | +$102K | |
| 4 |
BlackRock
New York
|
+$52.3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$46.7K |
Top Sellers
| 1 | -$112K | |
| 2 | -$92.7K | |
| 3 | -$88K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.84K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$1K |